Fact sheet: JPM Gbl Healthcare

Fund information

Fund name
JPM Global Healthcare A Acc NAV USD
Fund company manager
JPMorgan Asset Mgmt (Europe) S
Fund type
SIB
Fund manager
Matthew Cohen
since 05/01/2015
Fund objective
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

7.94 %

1 Year rank in sector

16/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.9 b

FE Risk score

144

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    62.2%
  • Europe & Middle East
    25.3%
  • UK
    10.4%
  • Japan
    1.2%
  • Money Market
    0.9%
  • Biotechnology/Medical
    44.2%
  • Pharmaceuticals
    37.6%
  • Health Care
    17.3%
  • Money Market
    0.9%
  • North American Equities
    67.6%
  • International Equities
    23.5%
  • UK Equities
    6.6%
  • Money Market
    1.2%
  • Japanese Equities
    1.1%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund1.09 %17.41 %8.88 %14.09 %117.36 %
Sector-0.08 %14.62 %10.05 %29.99 %111.7 %
Rank within sector11 / 3010 / 2916 / 2922 / 2610 / 23
Quartile th2 nd2 nd3 rd4 th2 nd

Calendar performance

YTD-20172016201520142013
Fund19.22 %-15.42 %2.14 %22.01 %61.04 %
Sector16.69 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector13 / 2922 / 2923 / 2719 / 244 / 23
Quartile th2 nd4 th4 th4 th1 st

Risk statistics

Alpha-3.74
Beta0.9
Sharpe0.01
Volatility14.37
Tracking error3.96
Information ratio-1.13
R-Squared0.93

Price movement

52 week high299.35
52 week low241.05
Current bid price0
Current offer price0
Current mid price299.35

Holdings by region

  • 62.2% North America
  • 25.3% Europe & Middle East
  • 10.4% UK
  • 1.2% Japan
  • 0.9% Money Market

Holdings by sector

  • 44.2% Biotechnology/Medical
  • 37.6% Pharmaceuticals
  • 17.3% Health Care
  • 0.9% Money Market

Holdings by asset type

  • 67.6% North American Equities
  • 23.5% International Equities
  • 6.6% UK Equities
  • 1.2% Money Market
  • 1.1% Japanese Equities

Individual holdings

  • 6.2% ROCHE HLDG AG
  • 5.6% UNITEDHEALTH GROUP INC
  • 4.2% CELGENE CORP
  • 3.8% BAYER AG
  • 3.6% SHIRE PLC
  • 3.3% BRISTOL MYERS SQUIBB SA
  • 3.3% LILLY (ELI) & CO
  • 3.1% ALLERGAN INC
  • 2.7% GLAXOSMITHKLINE
  • 2.7% JOHNSON & JOHNSON